pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4301 |
Genomic Coordinates | chr11: 113450023 - 113450088 |
Description | Homo sapiens miR-4301 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4301 | ||||||||||||||||||
Sequence | 11| UCCCACUACUUCACUUGUGA |30 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF354B | ||||||||||
Synonyms | KID2 | ||||||||||
Description | zinc finger protein 354B | ||||||||||
Transcript | NM_058230 | ||||||||||
Expression | |||||||||||
Putative miRNA Targets on ZNF354B | |||||||||||
3'UTR of ZNF354B (miRNA target sites are highlighted) |
>ZNF354B|NM_058230|3'UTR 1 AAGCCTTAAACCAAAACTCATCAGAGAATACATGCTTGAGAGTGATTTATTAAATATAATGAATATGAGAAAACTCTTAG 81 TTCTCATCAGATACTAAGTTTTAAGAATAAACTTTAGCTATGTAATAACTTAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||
DRVs in gene 3'UTRs | |||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 117608.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714643. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293/HeLa |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1067869. RNA binding protein: AGO2. Condition:Ago2 IP-seq (asynchronous cells)
HITS-CLIP data was present in GSM1067870. RNA binding protein: AGO2. Condition:Ago2 IP-seq (mitotic cells)
... - Kishore S; Gruber AR; Jedlinski DJ; Syed et al., 2013, Genome biology. |
Article |
- Kishore S; Gruber AR; Jedlinski DJ; Syed et al. - Genome biology, 2013
BACKGROUND: In recent years, a variety of small RNAs derived from other RNAs with well-known functions such as tRNAs and snoRNAs, have been identified. The functional relevance of these RNAs is largely unknown. To gain insight into the complexity of snoRNA processing and the functional relevance of snoRNA-derived small RNAs, we sequence long and short RNAs, small RNAs that co-precipitate with the Argonaute 2 protein and RNA fragments obtained in photoreactive nucleotide-enhanced crosslinking and immunoprecipitation (PAR-CLIP) of core snoRNA-associated proteins. RESULTS: Analysis of these data sets reveals that many loci in the human genome reproducibly give rise to C/D box-like snoRNAs, whose expression and evolutionary conservation are typically less pronounced relative to the snoRNAs that are currently cataloged. We further find that virtually all C/D box snoRNAs are specifically processed inside the regions of terminal complementarity, retaining in the mature form only 4-5 nucleotides upstream of the C box and 2-5 nucleotides downstream of the D box. Sequencing of the total and Argonaute 2-associated populations of small RNAs reveals that despite their cellular abundance, C/D box-derived small RNAs are not efficiently incorporated into the Ago2 protein. CONCLUSIONS: We conclude that the human genome encodes a large number of snoRNAs that are processed along the canonical pathway and expressed at relatively low levels. Generation of snoRNA-derived processing products with alternative, particularly miRNA-like, functions appears to be uncommon.
LinkOut: [PMID: 23706177]
|
CLIP-seq Support 1 for dataset GSM714643 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000322434.3 | 3UTR | ACUCAACUGCAUAAUUUAUGGUAGUGGGGGACUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1067869 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293/HeLa / Ago2 IP-seq (asynchronous cells) |
Location of target site | ENST00000322434.3 | 3UTR | AACUCAACUGCAUAAUUUAUGGUAGUGGGGGACUACAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23706177 / GSE43666 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1067870 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293/HeLa / Ago2 IP-seq (mitotic cells) |
Location of target site | ENST00000322434.3 | 3UTR | AACUCAACUGCAUAAUUUAUGGUAGUGGGGGACUAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23706177 / GSE43666 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000322434.3 | 3UTR | CUCAACUGCAUAAUUUAUGGUAGUGGGGGACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
83 hsa-miR-4301 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT081134 | LDLR | low density lipoprotein receptor | 2 | 4 | ||||||||
MIRT090911 | ARHGEF26 | Rho guanine nucleotide exchange factor 26 | 2 | 2 | ||||||||
MIRT229436 | MECP2 | methyl-CpG binding protein 2 | 2 | 2 | ||||||||
MIRT274717 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT350957 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT386722 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT446022 | PEX3 | peroxisomal biogenesis factor 3 | 2 | 2 | ||||||||
MIRT481303 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | 2 | 14 | ||||||||
MIRT483959 | ZNF354B | zinc finger protein 354B | 2 | 6 | ||||||||
MIRT495667 | TUBAL3 | tubulin alpha like 3 | 2 | 2 | ||||||||
MIRT496554 | TBX15 | T-box 15 | 2 | 2 | ||||||||
MIRT497702 | ARL6IP6 | ADP ribosylation factor like GTPase 6 interacting protein 6 | 2 | 2 | ||||||||
MIRT498105 | RMND5A | required for meiotic nuclear division 5 homolog A | 2 | 2 | ||||||||
MIRT512535 | SEMA4D | semaphorin 4D | 2 | 2 | ||||||||
MIRT512556 | MFN2 | mitofusin 2 | 2 | 6 | ||||||||
MIRT521465 | RABGAP1 | RAB GTPase activating protein 1 | 2 | 6 | ||||||||
MIRT526236 | C2orf15 | chromosome 2 open reading frame 15 | 2 | 2 | ||||||||
MIRT526743 | HLA-DOB | major histocompatibility complex, class II, DO beta | 2 | 2 | ||||||||
MIRT527578 | BRD7 | bromodomain containing 7 | 2 | 4 | ||||||||
MIRT528038 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT528267 | GPRIN2 | G protein regulated inducer of neurite outgrowth 2 | 2 | 2 | ||||||||
MIRT528505 | HTR7 | 5-hydroxytryptamine receptor 7 | 2 | 4 | ||||||||
MIRT528758 | RPS27 | ribosomal protein S27 | 2 | 6 | ||||||||
MIRT528999 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT529701 | MRPL30 | mitochondrial ribosomal protein L30 | 2 | 2 | ||||||||
MIRT529781 | C17orf82 | chromosome 17 open reading frame 82 | 2 | 2 | ||||||||
MIRT533797 | TMEM119 | transmembrane protein 119 | 2 | 6 | ||||||||
MIRT535308 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT535917 | MKL2 | MKL1/myocardin like 2 | 2 | 2 | ||||||||
MIRT544892 | OSBPL1A | oxysterol binding protein like 1A | 2 | 2 | ||||||||
MIRT555423 | PPIC | peptidylprolyl isomerase C | 2 | 2 | ||||||||
MIRT562068 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT565623 | SLC31A1 | solute carrier family 31 member 1 | 2 | 2 | ||||||||
MIRT565661 | SIX1 | SIX homeobox 1 | 2 | 2 | ||||||||
MIRT570138 | IL1RL2 | interleukin 1 receptor like 2 | 2 | 2 | ||||||||
MIRT571045 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT621232 | LMAN1 | lectin, mannose binding 1 | 2 | 2 | ||||||||
MIRT622272 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT623844 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT626158 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT626464 | CMKLR1 | chemerin chemokine-like receptor 1 | 2 | 2 | ||||||||
MIRT632087 | ALDH1A2 | aldehyde dehydrogenase 1 family member A2 | 2 | 2 | ||||||||
MIRT637243 | FAM26E | calcium homeostasis modulator family member 5 | 2 | 2 | ||||||||
MIRT642710 | FGFR1OP2 | FGFR1 oncogene partner 2 | 2 | 2 | ||||||||
MIRT643611 | KANSL3 | KAT8 regulatory NSL complex subunit 3 | 2 | 2 | ||||||||
MIRT644270 | PAFAH1B1 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 2 | 2 | ||||||||
MIRT645470 | SPIN3 | spindlin family member 3 | 2 | 2 | ||||||||
MIRT649193 | DNPEP | aspartyl aminopeptidase | 2 | 2 | ||||||||
MIRT650776 | POP4 | POP4 homolog, ribonuclease P/MRP subunit | 2 | 2 | ||||||||
MIRT651345 | ZC2HC1C | zinc finger C2HC-type containing 1C | 2 | 2 | ||||||||
MIRT652237 | TRAPPC3L | trafficking protein particle complex 3 like | 2 | 2 | ||||||||
MIRT652587 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT654591 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT654649 | PTAFR | platelet activating factor receptor | 2 | 2 | ||||||||
MIRT656842 | KLF7 | Kruppel like factor 7 | 2 | 2 | ||||||||
MIRT657209 | IKZF2 | IKAROS family zinc finger 2 | 2 | 2 | ||||||||
MIRT658513 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT659448 | CNNM2 | cyclin and CBS domain divalent metal cation transport mediator 2 | 2 | 2 | ||||||||
MIRT668816 | CYLD | CYLD lysine 63 deubiquitinase | 2 | 2 | ||||||||
MIRT669067 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 2 | ||||||||
MIRT677711 | ELOF1 | elongation factor 1 homolog | 2 | 4 | ||||||||
MIRT687146 | PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 2 | 2 | ||||||||
MIRT698498 | THOC2 | THO complex 2 | 2 | 2 | ||||||||
MIRT707930 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | 4 | 2 | ||||||||
MIRT708737 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT710031 | POLL | DNA polymerase lambda | 2 | 2 | ||||||||
MIRT712175 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT715297 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT716892 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 2 | ||||||||
MIRT717378 | RBM41 | RNA binding motif protein 41 | 2 | 2 | ||||||||
MIRT718082 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT718721 | ANKRD18A | ankyrin repeat domain 18A | 2 | 2 | ||||||||
MIRT719152 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 2 | ||||||||
MIRT719224 | CAMK4 | calcium/calmodulin dependent protein kinase IV | 2 | 2 | ||||||||
MIRT719528 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT719861 | KLF2 | Kruppel like factor 2 | 2 | 2 | ||||||||
MIRT720326 | CAMK2G | calcium/calmodulin dependent protein kinase II gamma | 2 | 2 | ||||||||
MIRT721596 | SREBF1 | sterol regulatory element binding transcription factor 1 | 2 | 2 | ||||||||
MIRT722020 | NEBL | nebulette | 2 | 2 | ||||||||
MIRT722484 | QSOX1 | quiescin sulfhydryl oxidase 1 | 2 | 2 | ||||||||
MIRT722614 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT723664 | RPTN | repetin | 2 | 2 | ||||||||
MIRT723939 | SVOP | SV2 related protein | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|